VerImmune Inc. announces over $3M Additional Funding

Funding follows VerImmune's successful FDA pre-IND meeting as well as completion of a key process development milestone. Participation occurred from existing investors as well as a pharmaceutical partner. Proceeds will be used to accelerate GLP/GMP ... Biopharmaceuticals, Oncology, Venture Capital VerImmune, Anti-tumor Immune Redirection
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news